Clinical Trial Update: Evaluation of Metronidazole Hydrogel 25% in Stage II and III Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a metronidazole 25% hydrogel for periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Metronidazole hydrogel 25% (Metronidazole)

Snippet

Sponsor: University of L'Aquila | Conditions: Periodontitis | Phase 4 | Status: COMPLETED